» Articles » PMID: 36381857

Comparative Analysis of Heller Myotomy With Dor Versus Toupet Fundoplication for Achalasia Cardia

Overview
Journal Cureus
Date 2022 Nov 16
PMID 36381857
Authors
Affiliations
Soon will be listed here.
Abstract

Background Heller myotomy (HM) with partial fundoplication is the standard of care for achalasia cardia. However, the choice of partial fundoplication is controversial. In this study, we compared both types of fundoplication concerning subjective and objective parameters. Methodology This prospective comparative study comprised a total of 30 consecutive patients who underwent laparoscopic/robotic HM with either Dor fundoplication (DF) (n = 15) or Toupet fundoplication (TF) (n = 15). Preoperative baseline characteristics, intraoperative details, and postoperative complications were recorded. Patients were followed with Eckardt score, quality of life-related scores, 24-hour pH study, and high-resolution manometry (HRM) at the one-year follow-up. Results There was no significant difference between the two groups regarding preoperative baseline parameters, length of hospital stay, and postoperative complications. The HM+DF group had four (27%) patients with recurrence/failure with none in the HM+TF, but it was not significant (p = 0.79). Symptom scores were similar between the groups at six and 12 months of follow-up. One patient in the HM+DF group and two in the HM+TF group had significant pathological acid reflux (p = 0.483). On HRM, HM+TF showed a trend toward significance in terms of esophagogastric junction (EGJ) relaxation (p = 0.058) with a non-significant difference in median integrated relaxation pressure (p = 0.081). Conclusions The study showed a trend toward lower failure rates and improved EGJ relaxation with similar reflux rates in patients who underwent HM+TF compared to HM+DF. However, long-term follow-up is required to validate our findings with well-defined subjective and objective criteria.

Citing Articles

Laparoscopic Heller myotomy with Toupet fundoplication: revisiting GERD in treated achalasia.

Blaustein M, Sillcox R, Wright A, Tatum R, Yates R, Bryant M Surg Endosc. 2023; 38(3):1283-1288.

PMID: 38102398 DOI: 10.1007/s00464-023-10643-4.

References
1.
Shiu S, Chang C, Tu Y, Ko C . The comparisons of different therapeutic modalities for idiopathic achalasia: A systematic review and network meta-analysis. Medicine (Baltimore). 2022; 101(24):e29441. PMC: 9276088. DOI: 10.1097/MD.0000000000029441. View

2.
El Nakeeb A, Ezzat H, Shehta A, El Gawad M, Abou El-Magd E, El Sorogy M . Impact of the Myotomy Extent on Gastric Side on Surgical Outcome After Heller's Cardiomotomy for Achalasia. Surg Laparosc Endosc Percutan Tech. 2019; 29(5):362-366. DOI: 10.1097/SLE.0000000000000647. View

3.
Patti M, Arcerito M, Tong J, De Pinto M , de Bellis M , Wang A . Importance of preoperative and postoperative pH monitoring in patients with esophageal achalasia. J Gastrointest Surg. 1998; 1(6):505-10. DOI: 10.1016/s1091-255x(97)80065-0. View

4.
Oelschlager B, Chang L, Pellegrini C . Improved outcome after extended gastric myotomy for achalasia. Arch Surg. 2003; 138(5):490-5; discussion 495-7. DOI: 10.1001/archsurg.138.5.490. View

5.
Teitelbaum E, Dunst C . The Role of Novel Functional Probes in the Evaluation and Treatment of Esophageal Disease. Thorac Surg Clin. 2018; 28(4):555-566. DOI: 10.1016/j.thorsurg.2018.07.007. View